939 / 1138
Long-term survival may be achieved in patients with
oligo-metastasis and favorable prognostic factors:
Good performance status/ acceptable co-morbidity
Small size of the metastases
Number of metastases
Metachronous metastasis
Previous systemic therapy
Morbidity is modetate
SBRT may be competable with other ablation methods
Conclusions – SBRT of oligometastases